Molecular characteristics of KRAS mutations in Chinese patients with cancer.

被引：0
|
作者：
Yan, Hui
Li, Mengmeng
Luo, Ningning
Qi, Yingxue
Sun, Tingting
Qi, Chuang
机构：
[1] Ningxia Med Univ, Gen Hosp, Yinchuan, TX, Peoples R China
[2] Jiangsu Simcere Diagnost Co Ltd, Dept Med, Nanjing, Peoples R China
[3] Nanjing Simcere Med Lab Sci Co Ltd, Nanjing, Peoples R China
[4] Jiangsu Simcere Diagnost Co Ltd, State Key Lab Translat Med & Innovat Drug Dev, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15070
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic indicators of KRAS G12X mutations in pancreatic cancer.
    Ardalan, Bach
    Ciner, Aaron
    Baca, Yasmine
    Darabi, Sourat
    Kasi, Anup
    Lou, Emil
    Azqueta, Jose Ignacio
    Xiu, Joanne
    Nabhan, Chadi
    Shields, Anthony Frank
    Pishvaian, Michael J.
    Korn, Wolfgang Michael
    Goel, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 735 - 735
  • [22] The landscape of germline mutations and the relationship with tumor mutation burden in Chinese patients with lung cancer.
    Shi, Jian
    Liu, Rongfeng
    Huang, Guanglei
    Wang, Lixing
    Shan, Baoen
    Luo, Ningning
    Zhang, Qin
    Guo, Didi
    Wu, Yaqing
    Qi, Yingxue
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Plasma cell-free DNA and fraction of circulating KRAS mutations as prognostic in patients with metastatic colorectal cancer.
    Sefrioui, David
    Vasseur, Nasrin
    Sesbouee, Richard
    Blanchard, France
    Oden-Gangloff, Alice
    Sabourin, Jean-Christophe
    Frebourg, Thierry
    Michel, Pierre
    Di Fiore, Frederic
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [24] KRAS mutations in patients with AML: clinical characteristics and not reported mutations using NGS
    Elsayed, Salma Said Ibrahim
    Deghady, Akram Abdel-Moneim
    Elneily, Dalia Abd Elmoat
    Elwafa, Reham Abdel Haleem Abo
    ALEXANDRIA JOURNAL OF MEDICINE, 2024, 60 (01) : 186 - 191
  • [25] Systematic interrogation of KRAS in cancer.
    Hahn, William C.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 27 - 27
  • [26] Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
    Koulouridi, Asimina
    Karagianni, Michaela
    Messaritakis, Ippokratis
    Sfakianaki, Maria
    Voutsina, Alexandra
    Trypaki, Maria
    Bachlitzanaki, Maria
    Koustas, Evangelos
    Karamouzis, Michalis, V
    Ntavatzikos, Anastasios
    Koumarianou, Anna
    Androulakis, Nikolaos
    Mavroudis, Dimitrios
    Tzardi, Maria
    Souglakos, John
    CANCERS, 2022, 14 (14)
  • [27] Genotyping of KRAS mutations in Bulgarian patients with colorectal cancer
    Bichev, S.
    Kremensky, I.
    Savov, A.
    Hristova, S.
    VIRCHOWS ARCHIV, 2011, 459 : S160 - S160
  • [28] KRAS mutations and subtyping in colorectal cancer in Jordanian patients
    Elbjeirami, Wafa M.
    Sughayer, Maher A.
    ONCOLOGY LETTERS, 2012, 4 (04) : 705 - 710
  • [29] KRAS and BRAF mutations in Serbian patients with colorectal cancer
    Jakovljevic, K.
    Malisic, E.
    Cavic, M.
    Krivokuca, A.
    Dobricic, J.
    Jankovic, R.
    JOURNAL OF BUON, 2012, 17 (03): : 575 - 580
  • [30] The prognostic value of KRAS mutations in patients with colorectal cancer
    Inoue, Yasuhiro
    Saigusa, Susumu
    Iwata, Takashi
    Okugawa, Yoshinaga
    Toiyama, Yuji
    Tanaka, Koji
    Uchida, Keiichi
    Mohri, Yasuhiko
    Kusunoki, Masato
    ONCOLOGY REPORTS, 2012, 28 (05) : 1579 - 1584
12345